Primary Results Of Ev-301: A Phase Iii Trial Of Enfortumab Vedotin Versus Chemotherapy In Patients With Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma.

Thomas Powles,Jonathan E. Rosenberg, Guru Sonpavde,Yohann Loriot,Ignacio Duran,Jae-Lyun Lee,Nobuaki Matsubara,Christof Vulsteke,Chunzhang Wu,Mary S. Campbell,Maria Matsangou,Daniel Peter Petrylak

JOURNAL OF CLINICAL ONCOLOGY（2021）

Cited 12|Views4

No score

Abstract

393Background: Patients with locally advanced or metastatic urothelial carcinoma (la/mUC) have poor survival following progression after platinum-containing chemotherapy and PD-1/L1 inhibitor regim...

Translated text

Key words

metastatic urothelial carcinoma,enfortumab vedotin,phase iii trial,chemotherapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined